G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2011
12/15/2011	WO2011155897A1 Arrangement for detection of hemolysis
12/15/2011	WO2011155890A1 Detection of magnetically labeled biological components
12/15/2011	WO2011155888A1 Procedure for hyperspectral image analysis in real time
12/15/2011	WO2011155818A1 Method for inspecting a collection of wooden parts
12/15/2011	WO2011155805A2 Radioisotope labeled folic acid conjugate human serum albumin specific to tumor and sentinel lymph node
12/15/2011	WO2011155531A1 Prediction of risk of onset of drug-induced pulmonary disorders, and method and kit for detection of gene for the prediction of the risk
12/15/2011	WO2011155489A1 Sample analysis device and sample analysis method
12/15/2011	WO2011155463A1 Method for quantitative evaluation of comfortableness of disposable diaper
12/15/2011	WO2011155435A1 Near field-enhanced fluorescence sensor chip
12/15/2011	WO2011154944A2 Apparatus and methods for collecting and analyzing olfactory samples
12/15/2011	WO2011154939A1 Functionalized nanostructures for detecting nitro - containing compounds
12/15/2011	WO2011154924A1 Methods and kits for the evaluation of a ruminant's diet
12/15/2011	WO2011154918A2 Diagnostic apparatus for immunoassay and diagnostic method for immunoassay using the same
12/15/2011	WO2011154698A2 Method,array and use thereof
12/15/2011	WO2011154655A2 Device and method intended to measure the properties of a complex medium by analysis of the variation in backscattered and/or transmitted light
12/15/2011	WO2011154650A2 Method for identifying mammalian cells by maldi-tof mass spectrometry on whole cells
12/15/2011	WO2011154640A2 Trmp1, mmp2, mia or ptgs1 modulators in the treatment of melasma
12/15/2011	WO2011154639A2 Edn3 and/or ednrb modulators in the treatment of melasma
12/15/2011	WO2011154616A2 Use of abo type
12/15/2011	WO2011154615A1 Method for isolating cd34+ hematopoietic stem cells, natural killer cells and regulatory t lymphocytes from a sample of human umbilical cord blood by using an anti-gd3 antibody, as well as compositions thereof
12/15/2011	WO2011154581A1 Structural variant of haemoglobin
12/15/2011	WO2011154570A1 Ghrelin variant and uses thereof
12/15/2011	WO2011154517A1 MASS SPECTROMETRIC MEASUREMENT OF β-LACTAMASE RESISTANCES
12/15/2011	WO2011154413A1 Agent against glucocorticoid-induced osteoporosis
12/15/2011	WO2011154321A1 Diagnostic and prognostic method for human tauopathies
12/15/2011	WO2011154261A2 Compound screening based on sebum composition
12/15/2011	WO2011154260A2 Detection of drug exposure based on sebum composition
12/15/2011	WO2011154259A1 Personal Identification Based on Sebum Composition
12/15/2011	WO2011154258A1 Method for analysis of sebum samples
12/15/2011	WO2011154170A1 Method and apparatus for determining the local spatial extent of the phase of valuable mineral in a rock
12/15/2011	WO2011154168A1 Method and apparatus for increasing the yield in a deposit
12/15/2011	WO2011154114A2 Method for producing a bilipid layer, and microstructure and measuring assembly
12/15/2011	WO2011154090A1 Liquid transporting and analytical testing device
12/15/2011	WO2011153650A1 Method and apparatus for optoelectronic determination of hairiness length distribution of a yarn
12/15/2011	WO2011153649A1 Device for determining features of a yarn
12/15/2011	WO2011153648A1 Apparatus for optoelectronic determination of features of a yarn
12/15/2011	WO2011153636A1 Wellbore screen with tracer for fluid detection
12/15/2011	WO2011153635A1 Wellbore fluid treatment tubular and method
12/15/2011	WO2011153590A1 Use of interferon epsilon in methods of diagnosis and treatment
12/15/2011	WO2011132175A3 Novel biomarkers and targets for ovarian carcinoma
12/15/2011	WO2011123041A8 Fertilization prediction and promotion
12/15/2011	WO2011114287A3 Molecular markers for urinary tract infections
12/15/2011	WO2011101670A3 Allergen microarray
12/15/2011	WO2011100392A3 Methionine gamma lyase-2-aminobutyrate (megl-2abd) and therapeutic uses thereof
12/15/2011	WO2011096756A3 Pharmaceutical composition for inhibiting abnormal proliferation of cells
12/15/2011	WO2011088014A3 Systems and methods for counting cells and biomolecules
12/15/2011	WO2011073896A8 Novel tumor markers
12/15/2011	WO2011027308A8 Novel tumor markers
12/15/2011	US20110307964 Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof
12/15/2011	US20110307184 Low perfusion signal processing systems and methods
12/15/2011	US20110306756 Prevention and Treatment of Amyloidogenic Disease
12/15/2011	US20110306651 Rna interference mediating small rna molecules
12/15/2011	US20110306631 Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases or conditions, or cancer
12/15/2011	US20110306628 Non-peptidyl, potent, and selective mu opioid receptor antagonists
12/15/2011	US20110306574 Inhibitors of f18+ e coli binding
12/15/2011	US20110306570 Na/K-Atpase Expression as an Indicator for the Treatment of Cancer
12/15/2011	US20110306557 Neural regeneration peptides and methods for their use in treatment of brain damage
12/15/2011	US20110306554 Peptide capable of binding to immunoglobulin
12/15/2011	US20110306553 Methods and uses involving heme binding protein 1
12/15/2011	US20110306540 Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment
12/15/2011	US20110306520 Methods, Kits and Compositions Pertaining to the Suppression of the Detectable Probe Binding to Randomly Distributed Repeat Sequences Genomic Nucleic Acid
12/15/2011	US20110306519 Method of forming polymeric microarray support
12/15/2011	US20110306517 Reducing irf4, dusp22, or flj43663 polypeptide expression
12/15/2011	US20110306516 Methods for producing induced pluripotent stem cells
12/15/2011	US20110306515 DEVICE FOR SEROLOGICALLY DETECTING YERSINIA INFECTIONS AND/OR SECONDARY DISEASES THEREOF AND USE OF THE PROTEINS MyfA AND PsaA OF Y. ENTEROCOLITICA AND Y. PSEUDOTUBERCULOSIS AS RECOMBINANT ANTIGENS
12/15/2011	US20110306514 Ratio based biomarkers and methods of use thereof
12/15/2011	US20110306513 Novel biomarker for liver cancer and applications for same
12/15/2011	US20110306510 Optimized pprobes and primers and methods of using same for the detection, screening, isolating and sequencing of mrsa, mssa staphylococcus markers, and the antibiotic resistance gene mec a
12/15/2011	US20110306509 Compositions and methods for the identification of inhibitors of protein synthesis
12/15/2011	US20110306508 Method of Mycotoxin Detection
12/15/2011	US20110306152 System and Method for Determining Concentration of a Predetermined Osteoarthritis Biomarker in a Urine Sample
12/15/2011	US20110306150 Allergen detection method using immunochromatography
12/15/2011	US20110306148 Composition for use as an assay reagent
12/15/2011	US20110306144 Mass spectrometric determination of derivatized methylmalonic acid
12/15/2011	US20110306143 Apparatus for single-molecule detection
12/15/2011	US20110306140 Molecular Heterobimetallic Chemodosimetric Sensor for the Detection of Biogenic Amines
12/15/2011	US20110306120 Assay device and methods
12/15/2011	US20110306118 Consumable hardware coding system
12/15/2011	US20110306071 Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
12/15/2011	US20110306070 Magnetic beads for reducing leukocyte interference in immunoassays
12/15/2011	US20110306069 Corin As A Marker For Heart Failure
12/15/2011	US20110306068 Method For Detecting And Removing Endotoxin
12/15/2011	US20110306067 Antibody Profiles Characteristic of Tuberculosis State
12/15/2011	US20110306066 Homogeneous activity test for determining enzymatic reactions
12/15/2011	US20110306064 Quantifiable Internal Reference Standards For Immunohistochemistry And Uses Thereof
12/15/2011	US20110306062 Babesia microti genomic clones containing novel antigens useful in the diagnosis of babesios
12/15/2011	US20110306061 Inhibitors of myelin-associated glycoprotein (mag) activity for regulating neural growth and regeneration
12/15/2011	US20110306060 Pcsk9 immunoassay
12/15/2011	US20110306059 Compositions and methods for measuring 3,6-l-ahg transferase activity and 3,6-l-ahg
12/15/2011	US20110306058 Method for the functional measurement of plasmatic thromboduline activity
12/15/2011	US20110306057 Phosphorylated RalA
12/15/2011	US20110306052 Form-Locking Gripping System
12/15/2011	US20110306049 Method for detecting gynecologic cancer
12/15/2011	US20110306047 Compositions and Methods for RNA Hybridization Applications
12/15/2011	US20110306044 Delta3, fthma-070, tango85, tango77, spoil, neokine, tango129, and integrin alpha subunit protein and nucleic acid molecules and uses thereof
12/15/2011	US20110306043 Devices and methods for enrichment and alteration of circulating tumor cells and other particles
12/15/2011	US20110306041 Device for cell culture
12/15/2011	US20110306040 Cpg receptor (cpg-r) and methods relating thereto
12/15/2011	US20110305803 Co-evolutionary product optimization
12/15/2011	US20110305722 Mage-c2 antigenic peptides and uses thereof

1 ... 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 ... 3937